Cryptococcomas have been described in AIDS patients in the setting of immune reconstitution inflammatory syndrome. We report the first case of human immunodeficiency virus-related inflammatory cerebral cryptococcoma to be treated with a recombinant human monoclonal tumor necrosis factor antagonist.
No takes yet. Share an insight, caveat, or question.
Sitapati et al. (2009) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: